Suzanne Vernon: Difference between revisions

From MEpedia, a crowd-sourced encyclopedia of ME and CFS science and history
m (Text replacement - "ref>{{Cite journal|last=Harvey|first=Jeanna M.|last2=Broderick|first2=Gordon|last3=Bowie|first3=Alanna|last4=Barnes|first4=Zachary M.|last5=Katz|first5=Ben Z.|last6=O’Gorman|first6=Maurice R. G.|last7=Vernon|first7=Suzanne D.|last...)
m (fix ref)
(2 intermediate revisions by the same user not shown)
Line 2: Line 2:
'''Suzanne D. Vernon''', PhD, is the Research Liaison at [[Bateman Horne Center]] of Excellence which specializes in treatment and research for [[ME/CFS]] and [[Fibromyalgia]]<ref name=":0">{{Cite web|url=https://batemanhornecenter.org/suzanne-d-vernon-phd/|title=Suzanne D. Vernon, PhD|website=Bateman Horne Center|language=en-US|access-date=2019-02-02}}</ref> and the Chief Scientific Revolutionary of The BioCollective, a collaborative that provides storage and sales of [[microbiome]] samples for research and development.<ref>http://www.thebiocollective.com/about-us/</ref>  
'''Suzanne D. Vernon''', PhD, is the Research Liaison at [[Bateman Horne Center]] of Excellence which specializes in treatment and research for [[ME/CFS]] and [[Fibromyalgia]]<ref name=":0">{{Cite web|url=https://batemanhornecenter.org/suzanne-d-vernon-phd/|title=Suzanne D. Vernon, PhD|website=Bateman Horne Center|language=en-US|access-date=2019-02-02}}</ref> and the Chief Scientific Revolutionary of The BioCollective, a collaborative that provides storage and sales of [[microbiome]] samples for research and development.<ref>http://www.thebiocollective.com/about-us/</ref>  


From November 2007 May 2015, Dr. Vernon was the Scientific Director of [[Solve ME/CFS Initiative]], formerly known as CFIDS Association of America.<ref>{{Cite web|url=https://solvecfs.org/suzanne-d-vernon-steps-down-from-scientific-director-post/|title=Suzanne D. Vernon Steps Down from Scientific Director Post|date=2015-04-08|website=Solve ME/CFS Initiative|language=en-US|access-date=2019-02-02}}</ref> While there she recognized that access to well-characterized clinical populations was a barrier to engaging more scientists in ME/CFS research. Thus, she started the Research Institute Without Walls (RIWW), "the first nonprofit patient-centered research initiative focused on identifying diagnostic biomarkers and disease-modifying treatment for ME/CFS.<ref name=":0" /> The core of RIWW is the [[SolveCFS BioBank & Patient Registry]].<ref>{{Cite web|url=https://solvecfs.org/about-us/advancing-science-a-case-for-hope-a-look-ahead/|title=Advancing Science: A Case for Hope, A Look Ahead|website=Solve ME/CFS Initiative|language=en-US|access-date=2019-06-25}}</ref>
From November 2007 to May 2015, Dr. Vernon was the Scientific Director of [[Solve ME/CFS Initiative]], formerly known as CFIDS Association of America.<ref>{{Cite web|url=https://solvecfs.org/suzanne-d-vernon-steps-down-from-scientific-director-post/|title=Suzanne D. Vernon Steps Down from Scientific Director Post|date=2015-04-08|website=Solve ME/CFS Initiative|language=en-US|access-date=2019-02-02}}</ref> While there she recognized that access to well-characterized clinical populations was a barrier to engaging more scientists in ME/CFS research. Thus, she started the Research Institute Without Walls (RIWW), "the first nonprofit patient-centered research initiative focused on identifying diagnostic biomarkers and disease-modifying treatment for ME/CFS.<ref name=":0" /> The core of RIWW is the [[SolveCFS BioBank & Patient Registry]].<ref>{{Cite web|url=https://solvecfs.org/about-us/advancing-science-a-case-for-hope-a-look-ahead/|title=Advancing Science: A Case for Hope, A Look Ahead|website=Solve ME/CFS Initiative|language=en-US|access-date=2019-06-25}}</ref>


From May 1990 October 2007, Dr. Vernon worked for the US [[Centers for Disease Control]], first on the team investigating the human papillomavirus as an opportunistic infection in HIV-infected woman, and then in 1997, she became the CFS research group team leader, under [[William Reeves]], MD, the Director of the CDC Chronic Fatigue Research Program.<ref>https://www.linkedin.com/in/suzanne-d-vernon-phd-2743a617</ref><ref>{{Cite news|url=https://www.nytimes.com/2012/08/09/health/dr-william-c-reeves-who-sought-cause-of-fatigue-syndrome-dies-at-69.html|title=Dr. William C. Reeves, Who Sought Cause of Fatigue Syndrome, Dies at 69|last=Grady|first=Denise|date=2012-08-08|work=The New York Times|access-date=2019-02-02|language=en-US|issn=0362-4331}}</ref>  
From May 1990 to October 2007, Dr. Vernon worked for the US [[Centers for Disease Control]], first on the team investigating the human papillomavirus as an opportunistic infection in HIV-infected woman, and then in 1997, she became the CFS research group team leader, under [[William Reeves]], MD, the Director of the CDC Chronic Fatigue Research Program.<ref>https://www.linkedin.com/in/suzanne-d-vernon-phd-2743a617</ref><ref>{{Cite news|url=https://www.nytimes.com/2012/08/09/health/dr-william-c-reeves-who-sought-cause-of-fatigue-syndrome-dies-at-69.html|title=Dr. William C. Reeves, Who Sought Cause of Fatigue Syndrome, Dies at 69|last=Grady|first=Denise|date=2012-08-08|work=The New York Times|access-date=2019-02-02|language=en-US|issn=0362-4331}}</ref>  


In 2005, Dr Vernon was one of the authors of the [[Centers for Disease Control and Prevention|CDC]] case definition of [[Chronic fatigue syndrome|CFS]], commonly called the [[Reeves criteria]].<ref name=":1">{{Cite journal|last=Reeves|first=William C|author-link=William Reeves|last2=Wagner|first2=Dieter|author-link2=|last3=Nisenbaum|first3=Rosane|author-link3=|last4=Jones|first4=James F|author-link4=|last5=Gurbaxani|first5=Brian|author-link5=|last6=Solomon|first6=Laura|author-link6=|last7=Papanicolaou|first7=Dimitris A|last8=Unger|first8=Elizabeth R|author-link8=Elizabeth Unger|last9=Vernon|first9=Suzanne D|author-link9=Suzanne Vernon|date=Dec 2005|title=Chronic Fatigue Syndrome – A clinically empirical approach to its definition and study|url=http://bmcmedicine.biomedcentral.com/articles/10.1186/1741-7015-3-19|journal=BMC Medicine|language=en|volume=3|issue=1|pages=|doi=10.1186/1741-7015-3-19|issn=1741-7015|quote=|via=}}</ref>
In 2005, Dr Vernon was one of the authors of the [[Centers for Disease Control and Prevention|CDC]] case definition of [[Chronic fatigue syndrome|CFS]], commonly called the [[Reeves criteria]].<ref name=":1">{{Cite journal|last=Reeves|first=William C|author-link=William Reeves|last2=Wagner|first2=Dieter|author-link2=|last3=Nisenbaum|first3=Rosane|author-link3=|last4=Jones|first4=James F|author-link4=|last5=Gurbaxani|first5=Brian|author-link5=|last6=Solomon|first6=Laura|author-link6=|last7=Papanicolaou|first7=Dimitris A|last8=Unger|first8=Elizabeth R|author-link8=Elizabeth Unger|last9=Vernon|first9=Suzanne D|author-link9=Suzanne Vernon|date=Dec 2005|title=Chronic Fatigue Syndrome – A clinically empirical approach to its definition and study|url=http://bmcmedicine.biomedcentral.com/articles/10.1186/1741-7015-3-19|journal=BMC Medicine|language=en|volume=3|issue=|pages=19|doi=10.1186/1741-7015-3-19|issn=1741-7015|quote=|via=}}</ref>


==Talks and interviews==
==Talks and interviews==
Line 16: Line 16:


==Studies and Articles==
==Studies and Articles==
*2003, Identification of ambiguities in the [[Fukuda criteria|1994 chronic fatigue syndrome research case definition]] and recommendations for resolution<ref name="Reeves,2003">{{Citation|last1=Reeves|first1=W.C.|authorlink1=William Reeves|last2=Lloyd|first2=A.|authorlink2=Andrew Lloyd|last3=Vernon|first3=S.D.|authorlink3=Suzanne Vernon|last4=Klimas|first4=N.|authorlink4=Nancy Klimas|last5=Jason|first5=L.A.|authorlink5=Leonard Jason|last6=Bleijenberg|first6=G.|authorlink6=Gijs Bleijenberg|last7=Evengard|first7=B.|authorlink7=Birgitta Evengård|last8=White|first8=P.D.|authorlink8=Peter White|last9=Nisenbaum|first9=R.|authorlink9=Rosane Nisenbaum|last10=Unger|first10=E.|authorlink10=Elizabeth Unger|title=Identification of ambiguities in the 1994 chronic fatigue syndrome research case definition and recommendations for resolution|journal=BMC Health Services Research|volume=3|issue=25|date=2003|doi=10.1186/1472-6963-3-25}}</ref> [https://bmchealthservres.biomedcentral.com/articles/10.1186/1472-6963-3-25 (Full Text)]
*2003, Identification of ambiguities in the [[Fukuda criteria|1994 chronic fatigue syndrome research case definition]] and recommendations for resolution<ref name="Reeves,2003">{{Cite journal |last1=Reeves|first1=W.C.|authorlink1=William Reeves|last2=Lloyd|first2=A.|authorlink2=Andrew Lloyd|last3=Vernon|first3=S.D.|authorlink3=Suzanne Vernon|last4=Klimas|first4=N.|authorlink4=Nancy Klimas|last5=Jason|first5=L.A.|authorlink5=Leonard Jason|last6=Bleijenberg|first6=G.|authorlink6=Gijs Bleijenberg|last7=Evengard|first7=B.|authorlink7=Birgitta Evengård|last8=White|first8=P.D.|authorlink8=Peter White|last9=Nisenbaum|first9=R.|authorlink9=Rosane Nisenbaum|last10=Unger|first10=E.|authorlink10=Elizabeth Unger|title=Identification of ambiguities in the 1994 chronic fatigue syndrome research case definition and recommendations for resolution|journal=BMC Health Services Research|volume=3|issue=|pages=25|url=https://bmchealthservres.biomedcentral.com/articles/10.1186/1472-6963-3-25|date=2003|doi=10.1186/1472-6963-3-25}}</ref> - [https://bmchealthservres.biomedcentral.com/articles/10.1186/1472-6963-3-25 (Full Text)]
*2003, Integration of [[gene expression]], clinical, and epidemiologic data to characterize Chronic Fatigue Syndrome<ref>{{Cite journal|last=Whistler|first=Toni|author-link=Toni Whistler|last2=Unger|first2=Elizabeth R.|author-link2=Elizabeth Unger|last3=Nisenbaum|first3=Rosane|author-link3=Rosane Nisenbaum|last4=Vernon|first4=Suzanne D.|author-link4=Suzanne Vernon|author-link5=|date=Dec 1, 2003|title=Integration of gene expression, clinical, and epidemiologic data to characterize Chronic Fatigue Syndrome|url=https://doi.org/10.1186/1479-5876-1-10|journal=Journal of Translational Medicine|volume=1|issue=1|pages=10|doi=10.1186/1479-5876-1-10|issn=1479-5876|pmc=305360|pmid=14641939|quote=|via=}}</ref> [https://doi.org/10.1186/1479-5876-1-10 (Full Text)]
*2003, Integration of [[gene expression]], clinical, and epidemiologic data to characterize Chronic Fatigue Syndrome<ref>{{Cite journal|last=Whistler|first=Toni|author-link=Toni Whistler|last2=Unger|first2=Elizabeth R.|author-link2=Elizabeth Unger|last3=Nisenbaum|first3=Rosane|author-link3=Rosane Nisenbaum|last4=Vernon|first4=Suzanne D.|author-link4=Suzanne Vernon|author-link5=|date=Dec 1, 2003|title=Integration of gene expression, clinical, and epidemiologic data to characterize Chronic Fatigue Syndrome|url=https://doi.org/10.1186/1479-5876-1-10|journal=Journal of Translational Medicine|volume=1|issue=|pages=10|doi=10.1186/1479-5876-1-10|issn=1479-5876|pmc=305360|pmid=14641939|quote=|via=}}</ref> - [https://doi.org/10.1186/1479-5876-1-10 (Full Text)]
*2004, Differential-display PCR of peripheral blood for biomarker discovery in chronic fatigue syndrome<ref>{{Cite journal|last=Rajeevan|first=Mangalathu S.|author-link=Mangalathu Rajeevan|last2=Jones|first2=James F.|author-link2=|last3=Vernon|first3=Suzanne D.|author-link3=Suzanne Vernon|last4=Unger|first4=Elizabeth R.|author-link4=Elizabeth Unger|last5=Steinau|first5=Martin|author-link5=|date=2004-11-01|title=Differential-display PCR of peripheral blood for biomarker discovery in chronic fatigue syndrome|url=https://link.springer.com/article/10.1007/s00109-004-0586-4|journal=Journal of Molecular Medicine|language=en|volume=82|issue=11|pages=750–755|doi=10.1007/s00109-004-0586-4|issn=1432-1440|quote=|via=}}</ref> [[pubmed:15490094|(Abstract)]]
*2004, Differential-display PCR of peripheral blood for biomarker discovery in chronic fatigue syndrome<ref>{{Cite journal|last=Rajeevan|first=Mangalathu S.|author-link=Mangalathu Rajeevan|last2=Jones|first2=James F.|author-link2=|last3=Vernon|first3=Suzanne D.|author-link3=Suzanne Vernon|last4=Unger|first4=Elizabeth R.|author-link4=Elizabeth Unger|last5=Steinau|first5=Martin|author-link5=|date=2004-11-01|title=Differential-display PCR of peripheral blood for biomarker discovery in chronic fatigue syndrome|url=https://link.springer.com/article/10.1007/s00109-004-0586-4|journal=Journal of Molecular Medicine|language=en|volume=82|issue=11|pages=750–755|doi=10.1007/s00109-004-0586-4|issn=1432-1440|quote=|via=}}</ref> - [[pubmed:15490094|(Abstract)]]
*2005, [[Chronic Fatigue Syndrome]] – A clinically empirical approach to its definition and study<ref name=":1" />
*2005, [[Chronic Fatigue Syndrome]] – A clinically empirical approach to its definition and study<ref name=":1" />
*2006, Post-infective and chronic fatigue syndromes precipitated by viral and non-viral pathogens: Prospective cohort study<ref>{{Cite journal|last=Hickie|first=Ian|author-link=Ian Hickie|last2=Davenport|first2=Tracey|author-link2=Tracey Davenport|last3=Wakefield|first3=Denis|author-link3=Denis Wakefield|last4=Vollmer-Conna|first4=Ute|author-link4=Uté Vollmer-Conna|last5=Cameron|first5=Barbara|author-link5=Barbara Cameron|last6=Vernon|first6=Suzanne D|author-link6=Suzanne Vernon|last7=Reeves|first7=William C|author-link7=William Reeves|last8=Lloyd|first8=Andrew|author-link8=Andrew Lloyd|date=2006-09-16|title=Post-infective and chronic fatigue syndromes precipitated by viral and non-viral pathogens: prospective cohort study|url=http://www.bmj.com/lookup/doi/10.1136/bmj.38933.585764.AE|journal=BMJ|volume=333|issue=7568|pages=575–|doi=10.1136/bmj.38933.585764.ae|pmc=1569956|pmid=16950834|quote=|via=}}</ref>[https://www.researchgate.net/publication/6838807_Post-infective_and_chronic_fatigue_syndromes_precipitated_by_viral_and_non-viral_pathogens_Prospective_cohort_study (Abstract)]
*2006, Post-infective and chronic fatigue syndromes precipitated by viral and non-viral pathogens: Prospective cohort study<ref>{{Cite journal|last=Hickie|first=Ian|author-link=Ian Hickie|last2=Davenport|first2=Tracey|author-link2=Tracey Davenport|last3=Wakefield|first3=Denis|author-link3=Denis Wakefield|last4=Vollmer-Conna|first4=Ute|author-link4=Uté Vollmer-Conna|last5=Cameron|first5=Barbara|author-link5=Barbara Cameron|last6=Vernon|first6=Suzanne D|author-link6=Suzanne Vernon|last7=Reeves|first7=William C|author-link7=William Reeves|last8=Lloyd|first8=Andrew|author-link8=Andrew Lloyd|date=2006-09-16|title=Post-infective and chronic fatigue syndromes precipitated by viral and non-viral pathogens: prospective cohort study|url=http://www.bmj.com/lookup/doi/10.1136/bmj.38933.585764.AE|journal=BMJ|volume=333|issue=7568|pages=575–|doi=10.1136/bmj.38933.585764.ae|pmc=1569956|pmid=16950834|quote=|via=}}</ref> - [https://www.researchgate.net/publication/6838807_Post-infective_and_chronic_fatigue_syndromes_precipitated_by_viral_and_non-viral_pathogens_Prospective_cohort_study (Abstract)]
*2006, Preliminary evidence of [[mitochondrion|mitochondrial]] dysfunction associated with post-infective fatigue after acute infection with Epstein Barr Virus<ref name="Vernon, 2006" /> [https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1373655/ (Full Text)]
*2006, Preliminary evidence of [[mitochondrion|mitochondrial]] dysfunction associated with post-infective fatigue after acute infection with Epstein Barr Virus<ref name="Vernon, 2006" /> - [https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1373655/ (Full Text)]
*2008, Neuroendocrine and immune network remodeling in chronic fatigue syndrome: an exploratory analysis<ref name="Fuite, 2010" /> [https://www.sciencedirect.com/science/article/pii/S0888754308001948?via%3Dihub (Full Text)]
*2008, Neuroendocrine and immune network remodeling in chronic fatigue syndrome: an exploratory analysis<ref name="Fuite, 2010" /> - [https://www.sciencedirect.com/science/article/pii/S0888754308001948 (Full Text)]
*2008, Evidence of inflammatory immune signaling in [[chronic fatigue syndrome]]: A pilot study of gene expression in peripheral blood.<ref name="Aspler, 2008" /> [http://psycnet.apa.org/record/2008-15631-001 (Abstract)]
*2008, Evidence of inflammatory immune signaling in [[chronic fatigue syndrome]]: A pilot study of gene expression in peripheral blood.<ref name="Aspler, 2008" /> - [http://psycnet.apa.org/record/2008-15631-001 (Abstract)]
*2009, Transcriptional control of complement activation in an [[exercise]] model of [[chronic fatigue syndrome]]<ref>{{Cite journal|last=Sorensen|first=Bristol|author-link=|last2=Jones|first2=James F|author-link2=|last3=Vernon|first3=Suzanne D|author-link3=Suzanne Vernon|last4=Rajeevan|first4=Mangalathu S|author-link4=Mangalathu Rajeevan|author-link5=|date=Jan 2009|title=Transcriptional Control of Complement Activation in an Exercise Model of Chronic Fatigue Syndrome|url=https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2583111/|journal=Molecular Medicine|volume=15|issue=1-2|pages=34–42|doi=10.2119/molmed.2008.00098|pmc=2583111|pmid=19015737|quote=|via=}}</ref> [https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2583111/pdf/mol-15-34.pdf (Full text)]
*2009, Transcriptional control of complement activation in an [[exercise]] model of [[chronic fatigue syndrome]]<ref>{{Cite journal|last=Sorensen|first=Bristol|author-link=|last2=Jones|first2=James F|author-link2=|last3=Vernon|first3=Suzanne D|author-link3=Suzanne Vernon|last4=Rajeevan|first4=Mangalathu S|author-link4=Mangalathu Rajeevan|author-link5=|date=Jan 2009|title=Transcriptional Control of Complement Activation in an Exercise Model of Chronic Fatigue Syndrome|url=https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2583111/|journal=Molecular Medicine|volume=15|issue=1-2|pages=34–42|doi=10.2119/molmed.2008.00098|pmc=2583111|pmid=19015737|quote=|via=}}</ref> - [https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2583111/pdf/mol-15-34.pdf (Full text)]
*2012, [[Cytokine]] expression profiles of immune imbalance in post-[[mononucleosis]] chronic fatigue<ref name="Broderick, 2012" />
*2012, [[Cytokine]] expression profiles of immune imbalance in post-[[mononucleosis]] chronic fatigue<ref name="Broderick, 2012" /> -
*2014, No association found between the detection of either [[xenotropic murine leukemia virus-related virus]] or polytropic murine leukemia virus and [[chronic fatigue syndrome]] in a blinded, multi-site, prospective study by the establishment and use of the [[SolveCFS BioBank & Patient Registry|SolveCFS BioBank]]<ref>{{Cite journal|last=Irlbeck|first=David M.|last2=Vernon|first2=Suzanne D.|author-link2=Suzanne Vernon|last3=McCleary|first3=K. Kimberly|author-link3=Kim McCleary|last4=Bateman|first4=Lucinda|author-link4=Lucinda Bateman|last5=Klimas|first5=Nancy G.|author-link5=Nancy Klimas|last6=Lapp|first6=Charles W.|author-link6=Charles Lapp|last7=Peterson|first7=Daniel L.|author-link7=Daniel Peterson|last8=Brown|first8=James R.|last9=Remlinger|first9=Katja S.|date=2014|title=No association found between the detection of either xenotropic murine leukemia virus-related virus or polytropic murine leukemia virus and chronic fatigue syndrome in a blinded, multi-site, prospective study by the establishment and use of the SolveCFS BioBank|url=https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4236736/|journal=BMC Research Notes|volume=7|pages=461|doi=10.1186/1756-0500-7-461|via=|last10=Wilfret|last11=Gerondelis|first11=Peter|first10=David A.}}</ref> [https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4236736/ (Full Text)]
*2014, No association found between the detection of either [[xenotropic murine leukemia virus-related virus]] or polytropic murine leukemia virus and [[chronic fatigue syndrome]] in a blinded, multi-site, prospective study by the establishment and use of the [[SolveCFS BioBank & Patient Registry|SolveCFS BioBank]]<ref>{{Cite journal|last=Irlbeck|first=David M.|last2=Vernon|first2=Suzanne D.|author-link2=Suzanne Vernon|last3=McCleary|first3=K. Kimberly|author-link3=Kim McCleary|last4=Bateman|first4=Lucinda|author-link4=Lucinda Bateman|last5=Klimas|first5=Nancy G.|author-link5=Nancy Klimas|last6=Lapp|first6=Charles W.|author-link6=Charles Lapp|last7=Peterson|first7=Daniel L.|author-link7=Daniel Peterson|last8=Brown|first8=James R.|last9=Remlinger|first9=Katja S.|last10=Wilfret|last11=Gerondelis|first11=Peter|first10=David A.|date=2014|title=No association found between the detection of either xenotropic murine leukemia virus-related virus or polytropic murine leukemia virus and chronic fatigue syndrome in a blinded, multi-site, prospective study by the establishment and use of the SolveCFS BioBank|url=https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4236736/|journal=BMC Research Notes|volume=7|pages=461|doi=10.1186/1756-0500-7-461|via=}}</ref> - [https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4236736/ (Full Text)]
*2014, Examining case definition criteria for [[chronic fatigue syndrome]] and [[myalgic encephalomyelitis]]<ref name="Jason, LA, 2014" />
*2014, Examining case definition criteria for [[chronic fatigue syndrome]] and [[myalgic encephalomyelitis]]<ref name="Jason, LA, 2014" /> -
*2015, [[Chronic fatigue syndrome]] versus [[Systemic Exertion Intolerance Disease|systemic exertion intolerance disease]]]<ref name="Jason, Sunn, 2015" /> [http://www.tandfonline.com/doi/full/10.1080/21641846.2015.1051291 (Abstract)]
*2015, [[Chronic fatigue syndrome]] versus [[Systemic Exertion Intolerance Disease|systemic exertion intolerance disease]]]<ref name="Jason, Sunn, 2015" /> - [http://www.tandfonline.com/doi/full/10.1080/21641846.2015.1051291 (Abstract)] -
*2015, Comparing and contrasting consensus versus empirical domains<ref name="Jason, Kot, 2015" /> [http://www.tandfonline.com/doi/full/10.1080/21641846.2015.1017344 (Abstract)]
*2015, Comparing and contrasting consensus versus empirical domains<ref name="Jason, Kot, 2015" /> - [http://www.tandfonline.com/doi/full/10.1080/21641846.2015.1017344 (Abstract)] -
*2015, Changes in Gut and Plasma [[Microbiome]] following [[Exercise]] Challenge in [[ME/CFS|Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS)]]<ref name="Shukla, 2015" /> [https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4684203/ (Full Text)]
*2015, Changes in Gut and Plasma [[Microbiome]] following [[Exercise]] Challenge in [[ME/CFS|Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS)]]<ref name="Shukla, 2015" /> - [https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4684203/ (Full Text)]
*2016, The utility of patient-reported outcome measures among patients with [[ME/CFS|myalgic encephalomyelitis/chronic fatigue syndrome]]<ref name="Murdock, 2016">{{Cite journal| last1  = Murdock          | first1 = KW              | authorlink1 =  
*2016, The utility of patient-reported outcome measures among patients with [[ME/CFS|myalgic encephalomyelitis/chronic fatigue syndrome]]<ref name="Murdock, 2016">{{Cite journal| last1  = Murdock          | first1 = KW              | authorlink1 =  
| last2  = Wang              | first2 = XS              | authorlink2 =  
| last2  = Wang              | first2 = XS              | authorlink2 =  
Line 36: Line 36:
| last4  = Cleeland          | first4 = CS              | authorlink4 =  
| last4  = Cleeland          | first4 = CS              | authorlink4 =  
| last5  = Fagundes          | first5 = CP              | authorlink5 =  
| last5  = Fagundes          | first5 = CP              | authorlink5 =  
| last6  = Vernon            | first6 = Suzanne D.      | authorlink6 = Suzanne Vernon| title  = The utility of patient-reported outcome measures among patients with myalgic encephalomyelitis/chronic fatigue syndrome.| journal = Quality of Life Research    | volume = 26  | issue =  | pages = 913–921 | date    = 2016| pmid    = 27600520 | pmc = PMC5336422| doi    = 10.1007/s11136-016-1406-3 | url = https://link.springer.com/article/10.1007/s11136-016-1406-3}}</ref> [https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5336422/ (Full Text)]
| last6  = Vernon            | first6 = Suzanne D.      | authorlink6 = Suzanne Vernon| title  = The utility of patient-reported outcome measures among patients with myalgic encephalomyelitis/chronic fatigue syndrome.| journal = Quality of Life Research    | volume = 26  | issue =  | pages = 913–921 | date    = 2016| pmid    = 27600520 | pmc = PMC5336422| doi    = 10.1007/s11136-016-1406-3 | url = https://link.springer.com/article/10.1007/s11136-016-1406-3}}</ref> -[https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5336422/ (Full Text)]
*2016, Tracking post-infectious fatigue in clinic using routine Lab tests<ref name="Harvey2016">{{Cite journal|last=Harvey|first=Jeanna M.|author-link=Jeanna Harvey|last2=Broderick|first2=Gordon|author-link2=Gordon Broderick|last3=Bowie|first3=Alanna|author-link3=Alanna Bowie|last4=Barnes|first4=Zachary M.|author-link4=Zachary Barnes|last5=Katz|first5=Ben Z.|author-link5=Ben Katz|last6=O'Gorman|first6=Maurice R. G.|author-link6=Maurice O'Gorman|last7=Vernon|first7=Suzanne D.|author-link7=Suzanne Vernon|last8=Fletcher|first8=Mary Ann|author-link8=Mary Ann Fletcher|last9=Klimas|first9=Nancy G.|author-link9=Nancy Klimas|date=2016-04-26|title=Tracking post-infectious fatigue in clinic using routine Lab tests|url=https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4847210/|journal=BMC Pediatrics|doi=10.1186/s12887-016-0596-8|issn=1471-2431|pmc=4847210|pmid=27118537|volume=15|issue=|pages=54|quote=|author-link=Jeanna Harvey|author-link2=Gordon Broderick|author-link3=|author-link4=Zachary Barnes|author-link5=Ben Katz|via=|author-link7=Suzanne Vernon|author-link8=Mary Ann Fletcher|author-link9=Nancy Klimas}}</ref> [https://bmcpediatr.biomedcentral.com/articles/10.1186/s12887-016-0596-8 (Full Text)]
*2016, Tracking post-infectious fatigue in clinic using routine Lab tests<ref name="Harvey2016">{{Cite journal|last=Harvey|first=Jeanna M.|author-link=Jeanna Harvey|last2=Broderick|first2=Gordon|author-link2=Gordon Broderick|last3=Bowie|first3=Alanna|author-link3=Alanna Bowie|last4=Barnes|first4=Zachary M.|author-link4=Zachary Barnes|last5=Katz|first5=Ben Z.|author-link5=Ben Katz|last6=O'Gorman|first6=Maurice R. G.|author-link6=Maurice O'Gorman|last7=Vernon|first7=Suzanne D.|author-link7=Suzanne Vernon|last8=Fletcher|first8=Mary Ann|author-link8=Mary Ann Fletcher|last9=Klimas|first9=Nancy G.|author-link9=Nancy Klimas|date=2016-04-26|title=Tracking post-infectious fatigue in clinic using routine Lab tests|url=https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4847210/|journal=BMC Pediatrics|doi=10.1186/s12887-016-0596-8|issn=1471-2431|pmc=4847210|pmid=27118537|volume=15|issue=|pages=54|quote=}}</ref> - [https://bmcpediatr.biomedcentral.com/articles/10.1186/s12887-016-0596-8 (Full Text)]
*2016, Current therapeutic strategies for [[ME/CFS|myalgic encephalomyelitis/chronic fatigue syndrome]]: results of an online survey<ref name="Deftereos, 2016" /> [http://www.tandfonline.com/doi/full/10.1080/21641846.2015.1126025 (Abstract)]
*2016, Current therapeutic strategies for [[ME/CFS|myalgic encephalomyelitis/chronic fatigue syndrome]]: results of an online survey<ref name="Deftereos, 2016" /> - [http://www.tandfonline.com/doi/full/10.1080/21641846.2015.1126025 (Abstract)]
*2016, Article - [https://batemanhornecenter.org/uncovering-biomarkers-fcg-receptors/ Uncovering Biomarkers– Fcg receptors in ME/CFS]
*2016, Article - [https://batemanhornecenter.org/uncovering-biomarkers-fcg-receptors/ Uncovering Biomarkers– Fcg receptors in ME/CFS]
*2016, Reductions in circulating levels of [[interleukin 16|IL-16]], [[interleukin 7|IL-7]] and [[VEGF]]-A in [[ME/CFS|myalgic encephalomyelitis/chronic fatigue syndrome]]<ref>{{Cite journal|last=Landi|first=Abdolamir|author-link=Amir Landi|last2=Broadhurst|first2=David|author-link2=|last3=Vernon|first3=Suzanne D.|author-link3=Suzanne Vernon|last4=Tyrrell|first4=D. Lorne J.|author-link4=|last5=Houghton|first5=Michael|author-link5=Michael Houghton|date=Feb 2016|title=Reductions in circulating levels of IL-16, IL-7 and VEGF-A in myalgic encephalomyelitis/chronic fatigue syndrome|url=https://linkinghub.elsevier.com/retrieve/pii/S1043466615301071|journal=Cytokine|language=en|volume=78|issue=|pages=27–36|doi=10.1016/j.cyto.2015.11.018|quote=|via=}}</ref>[http://www.sciencedirect.com/science/article/pii/S1043466615301071 (Full Text)]
*2016, Reductions in circulating levels of [[interleukin 16|IL-16]], [[interleukin 7|IL-7]] and [[VEGF]]-A in [[ME/CFS|myalgic encephalomyelitis/chronic fatigue syndrome]]<ref>{{Cite journal|last=Landi|first=Abdolamir|author-link=Amir Landi|last2=Broadhurst|first2=David|author-link2=|last3=Vernon|first3=Suzanne D.|author-link3=Suzanne Vernon|last4=Tyrrell|first4=D. Lorne J.|author-link4=|last5=Houghton|first5=Michael|author-link5=Michael Houghton|date=Feb 2016|title=Reductions in circulating levels of IL-16, IL-7 and VEGF-A in myalgic encephalomyelitis/chronic fatigue syndrome|url=https://linkinghub.elsevier.com/retrieve/pii/S1043466615301071|journal=Cytokine|language=en|volume=78|issue=|pages=27–36|doi=10.1016/j.cyto.2015.11.018|quote=|via=}}</ref> - [http://www.sciencedirect.com/science/article/pii/S1043466615301071 (Full Text)]
*2017, Epigenetic modifications and glucocorticoid sensitivity in [[ME/CFS|Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS)]]<ref name="de Vega, 2017" /> [https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5324230/ (Full Text)]
*2017, Epigenetic modifications and glucocorticoid sensitivity in [[ME/CFS|Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS)]]<ref name="de Vega, 2017" /> - [https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5324230/ (Full Text)]
*2017, Neural Consequences of [[post-exertional malaise|Post-Exertion Malaise]] in [[ME/CFS|Myalgic Encephalomyelitis/Chronic Fatigue Syndrome]]<ref name="Cook, 2017" /> [https://www.sciencedirect.com/science/article/pii/S088915911730051X?via%3Dihub (Full Text)]
*2017, Neural Consequences of [[post-exertional malaise|Post-Exertion Malaise]] in [[ME/CFS|Myalgic Encephalomyelitis/Chronic Fatigue Syndrome]]<ref name="Cook, 2017" /> - [https://www.sciencedirect.com/science/article/pii/S088915911730051X?via%3Dihub (Full Text)] -
*2018, A [[C-reactive protein]] response in patients with post-treatment [[Lyme]] Disease symptoms versus those with [[ME/CFS|Myalgic Encephalomyelitis/Chronic Fatigue Syndrome]]<ref name="Uhde, 2018 May 8" /> [https://www.ncbi.nlm.nih.gov/pubmed/29741589 (Abstract)]
*2018, A [[C-reactive protein]] response in patients with post-treatment [[Lyme]] Disease symptoms versus those with [[ME/CFS|Myalgic Encephalomyelitis/Chronic Fatigue Syndrome]]<ref name="Uhde, 2018 May 8" /> - [https://www.ncbi.nlm.nih.gov/pubmed/29741589 (Abstract)]
*2018, Integration of DNA methylation & health scores identifies subtypes in [[ME/CFS|myalgic encephalomyelitis/chronic fatigue syndrome]]<ref name="de Vega, 2018" /> [https://www.futuremedicine.com/doi/10.2217/epi-2017-0150 (Abstract)]
*2018, Integration of DNA methylation & health scores identifies subtypes in [[ME/CFS|myalgic encephalomyelitis/chronic fatigue syndrome]]<ref name="de Vega, 2018">{{Cite journal| last1  = de Vega        | first1 = Wilfred C.      | authorlink1 = Wilfred de Vega| last2  = Erdman        | first2 = Lauren          | authorlink2 = | last3  = Vernon        | first3 = Suzanne D.      | authorlink3 = Suzanne Vernon| last4  = Goldenberg    | first4 = Anna            | authorlink4 = | last5  = McGowan        | first5 = Patrick O.      | authorlink5 = Patrick McGowan| title  = Integration of DNA methylation & health scores identifies subtypes in myalgic encephalomyelitis/chronic fatigue syndrome| journal = Epigenomics  | volume = 10  | issue = 5  | pages = 539-557 | date    = 2018| url = https://www.futuremedicine.com/doi/10.2217/epi-2017-0150 | pmid    = | pmc = | doi    = 10.2217/epi-2017-0150}}</ref> - [https://www.futuremedicine.com/doi/10.2217/epi-2017-0150 (Abstract)]
*2018, Letter - Markers of non-coeliac wheat sensitivity in patients with [[ME/CFS|myalgic encephalomyelitis/chronic fatigue syndrome]]<ref name="Uhde, 2018" /> [http://gut.bmj.com/content/early/2018/03/17/gutjnl-2018-316133.long (Full Text)]
*2018, Letter - Markers of non-coeliac wheat sensitivity in patients with [[ME/CFS|myalgic encephalomyelitis/chronic fatigue syndrome]]<ref name="Uhde, 2018" /> - [http://gut.bmj.com/content/early/2018/03/17/gutjnl-2018-316133.long (Full Text)]
*2018, Genome-epigenome interactions associated with Myalgic Encephalomyelitis/Chronic Fatigue Syndrome<ref>{{Cite journal|last=Herrera|first=S|author-link=|last2=de Vega|first2=WC|author-link2=Wilfred de Vega|last3=Ashbrook|first3=D|author-link3=|last4=Vernon|first4=SD|author-link4=Suzanne Vernon|last5=McGowan|first5=PO|author-link5=Patrick McGowan|date=Dec 2018|title=Genome-epigenome interactions associated with Myalgic Encephalomyelitis/Chronic Fatigue Syndrome|url=|journal=Epigenetics|volume=13|issue=12|pages=1174-1190|doi=10.1080/15592294.2018.1549769|quote=|via=}}</ref> [https://www.ncbi.nlm.nih.gov/pubmed/30516085 (Abstract)]
*2018, Genome-epigenome interactions associated with Myalgic Encephalomyelitis/Chronic Fatigue Syndrome<ref>{{Cite journal|last=Herrera|first=S|author-link=|last2=de Vega|first2=WC|author-link2=Wilfred de Vega|last3=Ashbrook|first3=D|author-link3=|last4=Vernon|first4=SD|author-link4=Suzanne Vernon|last5=McGowan|first5=PO|author-link5=Patrick McGowan|date=Dec 2018|title=Genome-epigenome interactions associated with Myalgic Encephalomyelitis/Chronic Fatigue Syndrome|journal=Epigenetics|volume=13|issue=12|pages=1174-1190| url = https://www.ncbi.nlm.nih.gov/pubmed/30516085  | pmid = 30516085 |doi=10.1080/15592294.2018.1549769|quote=|via=}}</ref> - [https://www.ncbi.nlm.nih.gov/pubmed/30516085 (Abstract)]
*2019, Perturbation of effector and regulatory [[T cell]] subsets in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS)<ref>{{Cite journal|last=Karhan|first=Ece|last2=Gunter|first2=Courtney L|last3=Ravanmehr|first3=Vida|last4=Horne|first4=Meghan|last5=Kozhaya|first5=Lina|last6=Renzullo|first6=Stephanie|last7=Placek|first7=Lindsey|last8=George|first8=Joshy|last9=Robinson|first9=Peter N|last10=Vernon|first10=Suzanne D.|author-link10=Suzanne Vernon|last11=Bateman|first11=Lucinda|author-link11=Lucinda Bateman|last12=Unutmaz|first12=Derya|author-link12=Derya Unutmaz|date=2019-12-26|title=Perturbation of effector and regulatory T cell subsets in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS)|journal=biorxiv|url=http://biorxiv.org/lookup/doi/10.1101/2019.12.23.887505|language=en|doi=10.1101/2019.12.23.887505}}</ref> - [https://www.biorxiv.org/content/10.1101/2019.12.23.887505v1.full (Full text)]
*2019, Perturbation of effector and regulatory [[T cell]] subsets in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS)<ref>{{Cite journal|last=Karhan|first=Ece|last2=Gunter|first2=Courtney L|last3=Ravanmehr|first3=Vida|last4=Horne|first4=Meghan|last5=Kozhaya|first5=Lina|last6=Renzullo|first6=Stephanie|last7=Placek|first7=Lindsey|last8=George|first8=Joshy|last9=Robinson|first9=Peter N|last10=Vernon|first10=Suzanne D.|author-link10=Suzanne Vernon|last11=Bateman|first11=Lucinda|author-link11=Lucinda Bateman|last12=Unutmaz|first12=Derya|author-link12=Derya Unutmaz|date=2019-12-26|title=Perturbation of effector and regulatory T cell subsets in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS)|journal=biorxiv|url=http://biorxiv.org/lookup/doi/10.1101/2019.12.23.887505|doi=10.1101/2019.12.23.887505}}</ref> - [https://www.biorxiv.org/content/10.1101/2019.12.23.887505v1.full (Full text)]
*2020, Hemodynamics during the 10-minute NASA Lean Test: evidence of circulatory decompensation in a subset of ME/CFS patients<ref>{{Cite journal|last=Lee|first=Jihyun|author-link=|last2=Vernon|first2=Suzanne D.|author-link2=Suzanne Vernon|last3=Jeys|first3=Patricia|author-link3=|last4=Ali|first4=Weam|author-link4=|last5=Campos|first5=Andrea|author-link5=|last6=Unutmaz|first6=Derya|author-link6=Derya Unutmaz|last7=Yellman|first7=Brayden|last8=Bateman|first8=Lucinda|author-link8=Lucinda Bateman|date=Dec 2020|title=Hemodynamics during the 10-minute NASA Lean Test: evidence of circulatory decompensation in a subset of ME/CFS patients|url=https://translational-medicine.biomedcentral.com/articles/10.1186/s12967-020-02481-y|journal=Journal of Translational Medicine|language=en|volume=18|issue=1|pages=314|doi=10.1186/s12967-020-02481-y|issn=1479-5876|pmc =  7429890|pmid=32799889|access-date=|quote=|via=}}</ref> - [https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7429890/ (Full text)]
*2020, Hemodynamics during the 10-minute NASA Lean Test: evidence of circulatory decompensation in a subset of ME/CFS patients<ref>{{Cite journal|last=Lee|first=Jihyun|author-link=|last2=Vernon|first2=Suzanne D.|author-link2=Suzanne Vernon|last3=Jeys|first3=Patricia|author-link3=|last4=Ali|first4=Weam|author-link4=|last5=Campos|first5=Andrea|author-link5=|last6=Unutmaz|first6=Derya|author-link6=Derya Unutmaz|last7=Yellman|first7=Brayden|last8=Bateman|first8=Lucinda|author-link8=Lucinda Bateman|date=Dec 2020|title=Hemodynamics during the 10-minute NASA Lean Test: evidence of circulatory decompensation in a subset of ME/CFS patients|url=https://translational-medicine.biomedcentral.com/articles/10.1186/s12967-020-02481-y|journal=Journal of Translational Medicine|language=en|volume=18|issue=1|pages=314|doi=10.1186/s12967-020-02481-y|issn=1479-5876|pmc =  7429890|pmid=32799889|access-date=|quote=|via=}}</ref> - [https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7429890/ (Full text)]


Line 63: Line 63:
==References==
==References==
<references>
<references>
<ref name="Aspler, 2008">{{Citation
<ref name="Aspler, 2008">{{Cite journal | last1  = Aspler            | first1 = AL        | authorlink1 =  
| last1  = Aspler            | first1 = AL        | authorlink1 =  
| last2  = Bolshin          | first2 = C          | authorlink2 =  
| last2  = Bolshin          | first2 = C          | authorlink2 =  
| last3  = Vernon            | first3 = SD        | authorlink3 = Suzanne Vernon
| last3  = Vernon            | first3 = SD        | authorlink3 = Suzanne Vernon
| last4  = Broderick        | first4 = G          | authorlink4 = Gordon Broderick
| last4  = Broderick        | first4 = G          | authorlink4 = Gordon Broderick
| title  = Evidence of inflammatory immune signaling in chronic fatigue syndrome: A pilot study of gene expression in peripheral blood  
| title  = Evidence of inflammatory immune signaling in chronic fatigue syndrome: A pilot study of gene expression in peripheral blood  
| journal = Behavioral and Brain Functions    | volume = 4  | issue = 44  | page =  
| journal = Behavioral and Brain Functions    | volume = 4  | issue =   | pages = 44| date    = 2008 | url = https://behavioralandbrainfunctions.biomedcentral.com/articles/10.1186/1744-9081-4-44| pmid = | pmc =| doi    = 10.1186/1744-9081-4-44}}</ref>
| date    = 2008  
<ref name="Broderick, 2012">{{Cite journal
| doi    = 10.1186/1744-9081-4-44
}}
</ref>
<ref name="Broderick, 2012">{{Citation
| last1  = Broderick      | first1 = Gordon          | authorlink1 = Gordon Broderick
| last1  = Broderick      | first1 = Gordon          | authorlink1 = Gordon Broderick
| last2  = Katz          | first2 = Ben Z            | authorlink2 = Ben Katz
| last2  = Katz          | first2 = Ben Z            | authorlink2 = Ben Katz
Line 83: Line 78:
| last7  = O'Gorman      | first7 = Maurice RG      | authorlink7 =
| last7  = O'Gorman      | first7 = Maurice RG      | authorlink7 =
| last8  = Vernon        | first8 = Suzanne D        | authorlink8 = Suzanne Vernon
| last8  = Vernon        | first8 = Suzanne D        | authorlink8 = Suzanne Vernon
| last9  = Taylor        | first9 = Renee            | authorlink9 = Renee Taylor  
| last9  = Taylor        | first9 = Renee            | authorlink9 = Renee Taylor | title  = Cytokine expression profiles of immune imbalance in post-mononucleosis chronic fatigue
| title  = Cytokine expression profiles of immune imbalance in post-mononucleosis chronic fatigue
| journal = Journal of Translational Medicine    | volume = 10  | issue =    | pages = 191 | url = https://translational-medicine.biomedcentral.com/articles/10.1186/1479-5876-10-191 | date    = 2012
| journal = Journal of Translational Medicine    | volume = 10  | issue = 191   | page =  
| doi    = 10.1186/1479-5876-10-191}}</ref>
| date    = 2012
<ref name="Cook, 2017">{{Cite journal
| doi    = 10.1186/1479-5876-10-191
}}
</ref>
<ref name="Cook, 2017">{{Citation
| last1  = Cook          | first1 = Dane B.          | authorlink1 = Dane Cook
| last1  = Cook          | first1 = Dane B.          | authorlink1 = Dane Cook
| last2  = Light        | first2 = Alan R.          | authorlink2 = Alan Light
| last2  = Light        | first2 = Alan R.          | authorlink2 = Alan Light
Line 101: Line 92:
| last9  = Stegner      | first9 = Aaron J.          | authorlink9 =  
| last9  = Stegner      | first9 = Aaron J.          | authorlink9 =  
| last10  = Ellingson    | first10 = Laura D.        | authorlink10 =
| last10  = Ellingson    | first10 = Laura D.        | authorlink10 =
| last11  = Vernon        | first11 = Suzanne D.      | authorlink11 = Suzanne Vernon  
| last11  = Vernon        | first11 = Suzanne D.      | authorlink11 = Suzanne Vernon | title  = Neural Consequences of Post-Exertion Malaise in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome| journal = Brain, Behavior, and Immunity    | volume = 62   | issue =   | pages =87-99 | url = https://www.sciencedirect.com/science/article/pii/S088915911730051X | date    = 2017| pmid    = | doi    = 10.1016/j.bbi.2017.02.009}}</ref>
| title  = Neural Consequences of Post-Exertion Malaise in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome
<ref name="Deftereos, 2016">{{Cite journal | last1  = Deftereos      | first1 = S. N.            | authorlink1 =   
| journal = Brain, Behavior, and Immunity    | volume =    | issue =   | page =  
| date    = 2017
| pmid    =  
| doi    = 10.1016/j.bbi.2017.02.009
}}
</ref>
<ref name="Deftereos, 2016">{{Citation
| last1  = Deftereos      | first1 = S. N.            | authorlink1 =   
| last2  = Vernon          | first2 = S. D.            | authorlink2 = Suzanne Vernon
| last2  = Vernon          | first2 = S. D.            | authorlink2 = Suzanne Vernon
| last3  = Persidis        | first3 = A.                | authorlink3 =  
| last3  = Persidis        | first3 = A.                | authorlink3 = | title  = Current therapeutic strategies for myalgic encephalomyelitis/chronic fatigue syndrome: results of an online survey| journal = Fatigue: Biomedicine, Health & Behavior  | volume = 4 | issue = 1 | pages = 39-51 | url = http://www.tandfonline.com/doi/full/10.1080/21641846.2015.1126025
| title  = Current therapeutic strategies for myalgic encephalomyelitis/chronic fatigue syndrome: results of an online survey
| date    = 2016| pmid    = | doi    = 10.1080/21641846.2015.1126025}}</ref>
| journal = Fatigue: Biomedicine, Health & Behavior  | volume = 4 | issue = 1 | page = 39-51
<ref name="de Vega, 2017">{{Cite journal | last1  = de Vega        | first1 = Wilfred C.        | authorlink1 = Wilfred de Vega
| date    = 2016
| pmid    =  
| doi    = 10.1080/21641846.2015.1126025
}}
</ref>
<ref name="de Vega, 2017">{{Citation
| last1  = de Vega        | first1 = Wilfred C.        | authorlink1 = Wilfred de Vega
| last2  = Herrera        | first2 = Santiago          | authorlink2 =  
| last2  = Herrera        | first2 = Santiago          | authorlink2 =  
| last3  = Vernon        | first3 = Suzanne D.        | authorlink3 = Suzanne Vernon
| last3  = Vernon        | first3 = Suzanne D.        | authorlink3 = Suzanne Vernon
| last4  = McGowan        | first4 = Patrick O.        | authorlink4 = Patrick McGowan
| last4  = McGowan        | first4 = Patrick O.        | authorlink4 = Patrick McGowan| title  = Epigenetic modifications and glucocorticoid sensitivity in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS)| journal = BMC Med Genomics    | volume = 10  | issue =    | pages = 11 | url = https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5324230/ | date    = 2017
| title  = Epigenetic modifications and glucocorticoid sensitivity in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS)
| pmid    = | pmc = PMC5324230 | doi    = 10.1186/s12920-017-0248-3}}</ref>
| journal = BMC Med Genomics    | volume = 10  | issue = 11  | page =
<ref name="Fuite, 2010">{{Cite journal
| date   = 2017
| pmid    =  
| doi    = 10.1186/s12920-017-0248-3
}}
</ref>
<ref name="de Vega, 2018">{{Citation
| last1  = de Vega        | first1 = Wilfred C.       | authorlink1 = Wilfred de Vega
| last2  = Erdman        | first2 = Lauren          | authorlink2 =
| last3  = Vernon        | first3 = Suzanne D.       | authorlink3 = Suzanne Vernon
| last4  = Goldenberg    | first4 = Anna            | authorlink4 =
| last5  = McGowan        | first5 = Patrick O.       | authorlink5 = Patrick McGowan
| title  = Integration of DNA methylation & health scores identifies subtypes in myalgic encephalomyelitis/chronic fatigue syndrome
| journal = Epigenomics  | volume = 10  | issue = 5  | page =
| date    = 2018
| pmid    =  
| doi    = 10.2217/epi-2017-0150
}}
</ref>
<ref name="Fuite, 2010">{{Citation
| last1  = Fuite          | first1 = Jim          | authorlink1 =   
| last1  = Fuite          | first1 = Jim          | authorlink1 =   
| last2  = Vernon          | first2 = Suzanne      | authorlink2 = Suzanne Vernon  
| last2  = Vernon          | first2 = Suzanne      | authorlink2 = Suzanne Vernon  
| last3  = Broderick      | first3 = Gordon        | authorlink3 = Gordon Broderick   
| last3  = Broderick      | first3 = Gordon        | authorlink3 = Gordon Broderick   
| title  = Neuroendocrine and immune network re-modeling in chronic fatigue syndrome: an exploratory analysis.
| title  = Neuroendocrine and immune network re-modeling in chronic fatigue syndrome: an exploratory analysis.
| journal = Genomics   | volume = 92  | issue = 6  | page = 393-9
| journal = Genomics | url =  https://www.sciencedirect.com/science/article/pii/S0888754308001948 | volume = 92  | issue = 6  | pages = 393-9
| date    = 2008  
| date    = 2008 | pmid = 18775774 | pmc = | doi    = 10.1016/j.ygeno.2008.08.008}}</ref>
| doi    = 10.1016/j.ygeno.2008.08.008
<ref name="Jason, Kot, 2015">{{Cite journal | last1  = Jason          | first1 = LA          | authorlink1 = Leonard Jason
}}
</ref>
<ref name="Jason, Kot, 2015">{{Citation
| last1  = Jason          | first1 = LA          | authorlink1 = Leonard Jason
| last2  = Kot            | first2 = B          | authorlink2 =  
| last2  = Kot            | first2 = B          | authorlink2 =  
| last3  = Sunnquist      | first3 = M          | authorlink3 = Madison Sunnquist
| last3  = Sunnquist      | first3 = M          | authorlink3 = Madison Sunnquist
Line 164: Line 117:
| last7  = Newton          | first7 = JL          | authorlink7 = Julia Newton
| last7  = Newton          | first7 = JL          | authorlink7 = Julia Newton
| last8  = Strand          | first8 = EB          | authorlink8 = Elin Strand
| last8  = Strand          | first8 = EB          | authorlink8 = Elin Strand
| last9  = Vernon          | first9 = SD          | authorlink9 = Suzanne Vernon
| last9  = Vernon          | first9 = SD          | authorlink9 = Suzanne Vernon| title  = Comparing and Contrasting Consensus versus Empirical Domains| journal = Fatigue: biomedicine, health & behavior    | volume = 3  | issue = 2 | pages = 63-74| date    = 2015 | url = https://pubmed.ncbi.nlm.nih.gov/26977374| pmid    = 26977374 | doi    = 10.1080/21641846.2015.1017344}}</ref>
| title  = Comparing and Contrasting Consensus versus Empirical Domains
<ref name="Jason, LA, 2014">{{Cite journal | last1  = Jason          | first1 = Leonard A.      | authorlink1 = Leonard Jason
| journal = Fatigue: biomedicine, health & behavior    | volume = 3  | issue = 2   | page = 63-74
| date    = 2015 | url = https://pubmed.ncbi.nlm.nih.gov/26977374
| pmid    = 26977374 | doi    = 10.1080/21641846.2015.1017344}}</ref>
<ref name="Jason, LA, 2014">{{Citation
| last1  = Jason          | first1 = Leonard A.      | authorlink1 = Leonard Jason
| last2  = Sunnquist      | first2 = Madison          | authorlink2 = Madison Sunnquist
| last2  = Sunnquist      | first2 = Madison          | authorlink2 = Madison Sunnquist
| last3  = Brown          | first3 = Abigail          | authorlink3 = Abigail Brown
| last3  = Brown          | first3 = Abigail          | authorlink3 = Abigail Brown
Line 178: Line 126:
| last7  = Simonis        | first7 = Valerie          | authorlink7 =  
| last7  = Simonis        | first7 = Valerie          | authorlink7 =  
| title  = Examining case definition criteria for chronic fatigue syndrome and myalgic encephalomyelitis
| title  = Examining case definition criteria for chronic fatigue syndrome and myalgic encephalomyelitis
| journal = Fatigue: Biomedicine, Health & Behavior    | volume = 2  | issue = 1  | page = 40-56
| journal = Fatigue: Biomedicine, Health & Behavior    | volume = 2  | issue = 1  | pages = 40-56| date    = 2014| pmid    = | pmc =  PMC3912876 | url = https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3912876/ | doi    = 10.1080/21641846.2013.862993}}</ref>
| date    = 2014
<ref name="Jason, Sunn, 2015">{{Cite journal | last1  = Jason        | first1 = L.A.              | authorlink1 = Leonard Jason
| pmid    =  
| doi    = 10.1080/21641846.2013.862993
}}
</ref>
<ref name="Jason, Sunn, 2015">{{Citation
| last1  = Jason        | first1 = L.A.              | authorlink1 = Leonard Jason
| last2  = Sunnquist    | first2 = M.                | authorlink2 = Madison Sunnquist
| last2  = Sunnquist    | first2 = M.                | authorlink2 = Madison Sunnquist
| last3  = Brown        | first3 = A.                | authorlink3 = Abigail Brown
| last3  = Brown        | first3 = A.                | authorlink3 = Abigail Brown
| last4  = Newton        | first4 = J.L.              | authorlink4 = Julia Newton
| last4  = Newton        | first4 = J.L.              | authorlink4 = Julia Newton
| last5  = Strand        | first5 = E.B.              | authorlink5 = Elin Strand
| last5  = Strand        | first5 = E.B.              | authorlink5 = Elin Strand
| last6  = Vernon        | first6 = S.D.              | authorlink6 = Suzanne Vernon  
| last6  = Vernon        | first6 = S.D.              | authorlink6 = Suzanne Vernon | title  = Chronic fatigue syndrome versus systemic exertion intolerance disease| journal = Fatigue: Biomedicine, Health & Behavior | volume = 3 | issue = 3 | pages = 127-141| date    = 2015| url = http://www.tandfonline.com/doi/full/10.1080/21641846.2015.1051291 | pmid    = | doi    = 10.1080/21641846.2015.1051291 }}</ref>
| title  = Chronic fatigue syndrome versus systemic exertion intolerance disease
<ref name="Shukla, 2015">{{Cite journal | last1  = Shukla              | first1 = SK              | authorlink1 =  
| journal = Fatigue: Biomedicine, Health & Behavior | volume = 3 | issue = 3 | page = 127-141
| date    = 2015
| pmid    =  
| doi    = 10.1080/21641846.2015.1051291
}}</ref>
<ref name="Shukla, 2015">{{Citation
| last1  = Shukla              | first1 = SK              | authorlink1 =  
| last2  = Cook                | first2 = DB              | authorlink2 = Dane Cook  
| last2  = Cook                | first2 = DB              | authorlink2 = Dane Cook  
| last3  = Meyer              | first3 = J              | authorlink3 =  
| last3  = Meyer              | first3 = J              | authorlink3 =  
Line 208: Line 143:
| last9  = Yale                | first9 = S              | authorlink9 =  
| last9  = Yale                | first9 = S              | authorlink9 =  
| last10  = Frank              | first10 = DN            | authorlink10 =
| last10  = Frank              | first10 = DN            | authorlink10 =
| title  = Changes in Gut and Plasma Microbiome following Exercise Challenge in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS)
| title  = Changes in Gut and Plasma Microbiome following Exercise Challenge in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS)| journal =  PLoS One  | volume = 10  | issue = 12  | pages = e0145453| date    = 2015| url = https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4684203 | pmid    = | pmc = PMC468420 | doi    = 10.1371/journal.pone.0145453 }}</ref>
| journal =  PLoS One, 18   | volume = 10  | issue = 12  | page = e0145453
<ref name="Uhde, 2018">{{Cite journal
| date    = 2015
| pmid    =  
| doi    = 10.1371/journal.pone.0145453
}}
</ref>
<ref name="Uhde, 2018">{{Citation
| last1  = Uhde              | first1 = M                  | authorlink1 =  
| last1  = Uhde              | first1 = M                  | authorlink1 =  
| last2  = Indart            | first2 = AC                | authorlink2 =  
| last2  = Indart            | first2 = AC                | authorlink2 =  
Line 225: Line 154:
| last8  = Vernon            | first8 = SD                | authorlink8 = Suzanne Vernon
| last8  = Vernon            | first8 = SD                | authorlink8 = Suzanne Vernon
| last9  = Alaedini          | first9 = A                  | authorlink9 =  
| last9  = Alaedini          | first9 = A                  | authorlink9 =  
| title  = Markers of non-coeliac wheat sensitivity in patients with myalgic encephalomyelitis/chronic fatigue syndrome
| title  = Markers of non-coeliac wheat sensitivity in patients with myalgic encephalomyelitis/chronic fatigue syndrome| journal = Gut  | volume = 68 | issue =    | pages = 377-378 | url = https://gut.bmj.com/content/68/2/377 | date    = 2018
| journal = Gut  | volume =   | issue =    | page =  
| pmid    = | doi    = 10.1136/gutjnl-2018-316133}}</ref>
| date    = 2018
<ref name="Uhde, 2018 May 8">{{Cite journal | last1  = Uhde              | first1 = M                  | authorlink1 =  
| pmid    =  
| doi    = 10.1136/gutjnl-2018-316133
}}
</ref>
<ref name="Uhde, 2018 May 8">{{Citation
| last1  = Uhde              | first1 = M                  | authorlink1 =  
| last2  = Indart            | first2 = AC                | authorlink2 =  
| last2  = Indart            | first2 = AC                | authorlink2 =  
| last3  = Fallon            | first3 = BA                | authorlink3 =  
| last3  = Fallon            | first3 = BA                | authorlink3 =  
Line 240: Line 163:
| last6  = Vernon            | first6 = SD                | authorlink6 = Suzanne Vernon
| last6  = Vernon            | first6 = SD                | authorlink6 = Suzanne Vernon
| last7  = Alaedini          | first7 = A                  | authorlink7 =  
| last7  = Alaedini          | first7 = A                  | authorlink7 =  
| title  = C-reactive protein response in patients with post-treatment Lyme Disease symptoms versus those with Myalgic Encephalomyelitis/Chronic Fatigue Syndrome
| title  = C-reactive protein response in patients with post-treatment Lyme Disease symptoms versus those with Myalgic Encephalomyelitis/Chronic Fatigue Syndrome| journal = Clin Infect Dis  | volume = 67  | issue = 8 | pages = 1309-1310 | pmc = PMC6160605 | date    = 2018| pmid    = 29741589 | url = https://pubmed.ncbi.nlm.nih.gov/29741589| doi  = 10.1093/cid/ciy299}}</ref>
| journal = Clin Infect Dis  | volume =   | issue =   | page =  
<ref name="Vernon, 2006">{{Cite journal | last1  = Vernon            | first1 = SD                | authorlink1 = Suzanne Vernon
| date    = 2018| pmid    = 29741589 | url = https://pubmed.ncbi.nlm.nih.gov/29741589| doi  = 10.1093/cid/ciy299}}</ref>
<ref name="Vernon, 2006">{{Citation
| last1  = Vernon            | first1 = SD                | authorlink1 = Suzanne Vernon
| last2  = Whistler          | first2 = T                  | authorlink2 =  
| last2  = Whistler          | first2 = T                  | authorlink2 =  
| last3  = Cameron          | first3 = B                  | authorlink3 =  
| last3  = Cameron          | first3 = B                  | authorlink3 =  
| last4  = Hickie            | first4 = IB                | authorlink4 = Ian Hickie
| last4  = Hickie            | first4 = IB                | authorlink4 = Ian Hickie
| last5  = Reeves            | first5 = WC                | authorlink5 = William Reeves
| last5  = Reeves            | first5 = WC                | authorlink5 = William Reeves
| last6  = Lloyd            | first6 = A                  | authorlink6 = Andrew Lloyd
| last6  = Lloyd            | first6 = A                  | authorlink6 = Andrew Lloyd| title  = Preliminary evidence of mitochondrial dysfunction associated with post-infective fatigue after acute infection with Epstein Barr Virus| journal = BMC Infectious Diseases    | volume = 6  | issue = 15  | pages = | date    = 2006| pmid    = 16448567 | url = https://pubmed.ncbi.nlm.nih.gov/16448567| doi    = 10.1186/1471-2334-6-15}}</ref>
| title  = Preliminary evidence of mitochondrial dysfunction associated with post-infective fatigue after acute infection with Epstein Barr Virus| journal = BMC Infectious Diseases    | volume = 6  | issue = 15  | page = | date    = 2006| pmid    = 16448567 | url = https://pubmed.ncbi.nlm.nih.gov/16448567| doi    = 10.1186/1471-2334-6-15}}</ref>
</references>
</references>


[[Category:Researchers]]
[[Category:Researchers]]
[[Category:US researchers]]
[[Category:US researchers]]

Revision as of 01:26, May 17, 2022

SuzanneVernon.jpeg

Suzanne D. Vernon, PhD, is the Research Liaison at Bateman Horne Center of Excellence which specializes in treatment and research for ME/CFS and Fibromyalgia[1] and the Chief Scientific Revolutionary of The BioCollective, a collaborative that provides storage and sales of microbiome samples for research and development.[2]

From November 2007 to May 2015, Dr. Vernon was the Scientific Director of Solve ME/CFS Initiative, formerly known as CFIDS Association of America.[3] While there she recognized that access to well-characterized clinical populations was a barrier to engaging more scientists in ME/CFS research. Thus, she started the Research Institute Without Walls (RIWW), "the first nonprofit patient-centered research initiative focused on identifying diagnostic biomarkers and disease-modifying treatment for ME/CFS.[1] The core of RIWW is the SolveCFS BioBank & Patient Registry.[4]

From May 1990 to October 2007, Dr. Vernon worked for the US Centers for Disease Control, first on the team investigating the human papillomavirus as an opportunistic infection in HIV-infected woman, and then in 1997, she became the CFS research group team leader, under William Reeves, MD, the Director of the CDC Chronic Fatigue Research Program.[5][6]

In 2005, Dr Vernon was one of the authors of the CDC case definition of CFS, commonly called the Reeves criteria.[7]

Talks and interviews[edit | edit source]

Studies and Articles[edit | edit source]

Online presence[edit | edit source]

Learn more[edit | edit source]

See also[edit | edit source]

References[edit | edit source]

  1. 1.0 1.1 "Suzanne D. Vernon, PhD". Bateman Horne Center. Retrieved February 2, 2019.
  2. http://www.thebiocollective.com/about-us/
  3. "Suzanne D. Vernon Steps Down from Scientific Director Post". Solve ME/CFS Initiative. April 8, 2015. Retrieved February 2, 2019.
  4. "Advancing Science: A Case for Hope, A Look Ahead". Solve ME/CFS Initiative. Retrieved June 25, 2019.
  5. https://www.linkedin.com/in/suzanne-d-vernon-phd-2743a617
  6. Grady, Denise (August 8, 2012). "Dr. William C. Reeves, Who Sought Cause of Fatigue Syndrome, Dies at 69". The New York Times. ISSN 0362-4331. Retrieved February 2, 2019.
  7. 7.0 7.1 Reeves, William C; Wagner, Dieter; Nisenbaum, Rosane; Jones, James F; Gurbaxani, Brian; Solomon, Laura; Papanicolaou, Dimitris A; Unger, Elizabeth R; Vernon, Suzanne D (December 2005). "Chronic Fatigue Syndrome – A clinically empirical approach to its definition and study". BMC Medicine. 3: 19. doi:10.1186/1741-7015-3-19. ISSN 1741-7015.
  8. Reeves, W.C.; Lloyd, A.; Vernon, S.D.; Klimas, N.; Jason, L.A.; Bleijenberg, G.; Evengard, B.; White, P.D.; Nisenbaum, R.; Unger, E. (2003). "Identification of ambiguities in the 1994 chronic fatigue syndrome research case definition and recommendations for resolution". BMC Health Services Research. 3: 25. doi:10.1186/1472-6963-3-25.
  9. Whistler, Toni; Unger, Elizabeth R.; Nisenbaum, Rosane; Vernon, Suzanne D. (December 1, 2003). "Integration of gene expression, clinical, and epidemiologic data to characterize Chronic Fatigue Syndrome". Journal of Translational Medicine. 1: 10. doi:10.1186/1479-5876-1-10. ISSN 1479-5876. PMC 305360. PMID 14641939.
  10. Rajeevan, Mangalathu S.; Jones, James F.; Vernon, Suzanne D.; Unger, Elizabeth R.; Steinau, Martin (November 1, 2004). "Differential-display PCR of peripheral blood for biomarker discovery in chronic fatigue syndrome". Journal of Molecular Medicine. 82 (11): 750–755. doi:10.1007/s00109-004-0586-4. ISSN 1432-1440.
  11. Hickie, Ian; Davenport, Tracey; Wakefield, Denis; Vollmer-Conna, Ute; Cameron, Barbara; Vernon, Suzanne D; Reeves, William C; Lloyd, Andrew (September 16, 2006). "Post-infective and chronic fatigue syndromes precipitated by viral and non-viral pathogens: prospective cohort study". BMJ. 333 (7568): 575–. doi:10.1136/bmj.38933.585764.ae. PMC 1569956. PMID 16950834.
  12. Vernon, SD; Whistler, T; Cameron, B; Hickie, IB; Reeves, WC; Lloyd, A (2006). "Preliminary evidence of mitochondrial dysfunction associated with post-infective fatigue after acute infection with Epstein Barr Virus". BMC Infectious Diseases. 6 (15). doi:10.1186/1471-2334-6-15. PMID 16448567.
  13. Fuite, Jim; Vernon, Suzanne; Broderick, Gordon (2008). "Neuroendocrine and immune network re-modeling in chronic fatigue syndrome: an exploratory analysis". Genomics. 92 (6): 393–9. doi:10.1016/j.ygeno.2008.08.008. PMID 18775774.
  14. Aspler, AL; Bolshin, C; Vernon, SD; Broderick, G (2008). "Evidence of inflammatory immune signaling in chronic fatigue syndrome: A pilot study of gene expression in peripheral blood". Behavioral and Brain Functions. 4: 44. doi:10.1186/1744-9081-4-44.
  15. Sorensen, Bristol; Jones, James F; Vernon, Suzanne D; Rajeevan, Mangalathu S (January 2009). "Transcriptional Control of Complement Activation in an Exercise Model of Chronic Fatigue Syndrome". Molecular Medicine. 15 (1–2): 34–42. doi:10.2119/molmed.2008.00098. PMC 2583111. PMID 19015737.
  16. Broderick, Gordon; Katz, Ben Z; Fernandes, Henrique; Fletcher, Mary Ann; Klimas, Nancy; Smith, Frederick A; O'Gorman, Maurice RG; Vernon, Suzanne D; Taylor, Renee (2012). "Cytokine expression profiles of immune imbalance in post-mononucleosis chronic fatigue". Journal of Translational Medicine. 10: 191. doi:10.1186/1479-5876-10-191.
  17. Irlbeck, David M.; Vernon, Suzanne D.; McCleary, K. Kimberly; Bateman, Lucinda; Klimas, Nancy G.; Lapp, Charles W.; Peterson, Daniel L.; Brown, James R.; Remlinger, Katja S.; Wilfret, David A.; Gerondelis, Peter (2014). "No association found between the detection of either xenotropic murine leukemia virus-related virus or polytropic murine leukemia virus and chronic fatigue syndrome in a blinded, multi-site, prospective study by the establishment and use of the SolveCFS BioBank". BMC Research Notes. 7: 461. doi:10.1186/1756-0500-7-461.
  18. Jason, Leonard A.; Sunnquist, Madison; Brown, Abigail; Evans, Meredyth; Vernon, Suzanne D.; Furst, Jacob D.; Simonis, Valerie (2014). "Examining case definition criteria for chronic fatigue syndrome and myalgic encephalomyelitis". Fatigue: Biomedicine, Health & Behavior. 2 (1): 40–56. doi:10.1080/21641846.2013.862993. PMC 3912876.
  19. Jason, L.A.; Sunnquist, M.; Brown, A.; Newton, J.L.; Strand, E.B.; Vernon, S.D. (2015). "Chronic fatigue syndrome versus systemic exertion intolerance disease". Fatigue: Biomedicine, Health & Behavior. 3 (3): 127–141. doi:10.1080/21641846.2015.1051291.
  20. Jason, LA; Kot, B; Sunnquist, M; Brown, A; Reed, J; Furst, J; Newton, JL; Strand, EB; Vernon, SD (2015). "Comparing and Contrasting Consensus versus Empirical Domains". Fatigue: biomedicine, health & behavior. 3 (2): 63–74. doi:10.1080/21641846.2015.1017344. PMID 26977374.
  21. Shukla, SK; Cook, DB; Meyer, J; Vernon, SD; Le, T; Clevidence, D; Robertson, CE; Schrodi, SJ; Yale, S; Frank, DN (2015). "Changes in Gut and Plasma Microbiome following Exercise Challenge in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS)". PLoS One. 10 (12): e0145453. doi:10.1371/journal.pone.0145453. PMC 468420.
  22. Murdock, KW; Wang, XS; Shi, Q; Cleeland, CS; Fagundes, CP; Vernon, Suzanne D. (2016). "The utility of patient-reported outcome measures among patients with myalgic encephalomyelitis/chronic fatigue syndrome". Quality of Life Research. 26: 913–921. doi:10.1007/s11136-016-1406-3. PMC 5336422. PMID 27600520.
  23. Harvey, Jeanna M.; Broderick, Gordon; Bowie, Alanna; Barnes, Zachary M.; Katz, Ben Z.; O'Gorman, Maurice R. G.; Vernon, Suzanne D.; Fletcher, Mary Ann; Klimas, Nancy G. (April 26, 2016). "Tracking post-infectious fatigue in clinic using routine Lab tests". BMC Pediatrics. 15: 54. doi:10.1186/s12887-016-0596-8. ISSN 1471-2431. PMC 4847210. PMID 27118537.
  24. Deftereos, S. N.; Vernon, S. D.; Persidis, A. (2016). "Current therapeutic strategies for myalgic encephalomyelitis/chronic fatigue syndrome: results of an online survey". Fatigue: Biomedicine, Health & Behavior. 4 (1): 39–51. doi:10.1080/21641846.2015.1126025.
  25. Landi, Abdolamir; Broadhurst, David; Vernon, Suzanne D.; Tyrrell, D. Lorne J.; Houghton, Michael (February 2016). "Reductions in circulating levels of IL-16, IL-7 and VEGF-A in myalgic encephalomyelitis/chronic fatigue syndrome". Cytokine. 78: 27–36. doi:10.1016/j.cyto.2015.11.018.
  26. de Vega, Wilfred C.; Herrera, Santiago; Vernon, Suzanne D.; McGowan, Patrick O. (2017). "Epigenetic modifications and glucocorticoid sensitivity in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS)". BMC Med Genomics. 10: 11. doi:10.1186/s12920-017-0248-3. PMC 5324230.
  27. Cook, Dane B.; Light, Alan R.; Light, Kathleen C.; Broderick, Gordon; Shields, Morgan R.; Dougherty, Ryan J.; Meyer, Jacob D.; VanRiper, Stephanie; Stegner, Aaron J.; Ellingson, Laura D.; Vernon, Suzanne D. (2017). "Neural Consequences of Post-Exertion Malaise in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome". Brain, Behavior, and Immunity. 62: 87–99. doi:10.1016/j.bbi.2017.02.009.
  28. Uhde, M; Indart, AC; Fallon, BA; Wormser, GP; Marques, AR; Vernon, SD; Alaedini, A (2018). "C-reactive protein response in patients with post-treatment Lyme Disease symptoms versus those with Myalgic Encephalomyelitis/Chronic Fatigue Syndrome". Clin Infect Dis. 67 (8): 1309–1310. doi:10.1093/cid/ciy299. PMC 6160605. PMID 29741589.
  29. de Vega, Wilfred C.; Erdman, Lauren; Vernon, Suzanne D.; Goldenberg, Anna; McGowan, Patrick O. (2018). "Integration of DNA methylation & health scores identifies subtypes in myalgic encephalomyelitis/chronic fatigue syndrome". Epigenomics. 10 (5): 539–557. doi:10.2217/epi-2017-0150.
  30. Uhde, M; Indart, AC; Yu, XB; Jang, SS; De Giorgio, R; Green, PHR; Volta, U; Vernon, SD; Alaedini, A (2018). "Markers of non-coeliac wheat sensitivity in patients with myalgic encephalomyelitis/chronic fatigue syndrome". Gut. 68: 377–378. doi:10.1136/gutjnl-2018-316133.
  31. Herrera, S; de Vega, WC; Ashbrook, D; Vernon, SD; McGowan, PO (December 2018). "Genome-epigenome interactions associated with Myalgic Encephalomyelitis/Chronic Fatigue Syndrome". Epigenetics. 13 (12): 1174–1190. doi:10.1080/15592294.2018.1549769. PMID 30516085.
  32. Karhan, Ece; Gunter, Courtney L; Ravanmehr, Vida; Horne, Meghan; Kozhaya, Lina; Renzullo, Stephanie; Placek, Lindsey; George, Joshy; Robinson, Peter N; Vernon, Suzanne D.; Bateman, Lucinda; Unutmaz, Derya (December 26, 2019). "Perturbation of effector and regulatory T cell subsets in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS)". biorxiv. doi:10.1101/2019.12.23.887505.
  33. Lee, Jihyun; Vernon, Suzanne D.; Jeys, Patricia; Ali, Weam; Campos, Andrea; Unutmaz, Derya; Yellman, Brayden; Bateman, Lucinda (December 2020). "Hemodynamics during the 10-minute NASA Lean Test: evidence of circulatory decompensation in a subset of ME/CFS patients". Journal of Translational Medicine. 18 (1): 314. doi:10.1186/s12967-020-02481-y. ISSN 1479-5876. PMC 7429890. PMID 32799889.